
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B

Dr. Gator’s latest update adds a new chapter to *Between a Shot and a Hard Place*, reflecting a year of rapid shifts in U.S. vaccine policy, legal battles, and scientific debate. The chapter details CDC schedule changes that now mirror Denmark, the removal of routine newborn Hep B shots, and a move toward single‑dose HPV recommendations. It also outlines a surge in vaccine‑related litigation, including the AAP’s lawsuit against HHS and a landmark VICP encephalopathy case. The author positions the update as a non‑partisan guide to the evolving terrain.
This is a recurrent fiasco. Health care companies that now the serious risk of their device or drug but keep selling it and do not acknowledge the hazard. Until so many people are harmed. Today's front page @nytimes by @katie_thomas @bostonsci...
Malaria remains a leading health threat in Papua New Guinea, prompting the NATNAT project to evaluate supplementary vector control tools such as residual indoor spraying, spatial emanators, and larval source management. A qualitative study across four Madang Province villages used...

Phoenix Hospital Group has launched a Prostate MRI Cancer Screening Service at its Harley Street hospital in London and at Phoenix Chelmsford Hospital, with the offering also extended to its Hatfield and Ashford sites. The package includes an in‑person urologist...
Pediatric health coaching is being promoted as a workforce‑driven strategy to bridge the gap between clinical guidelines and real‑world behavior change for childhood obesity. Experts from the Pediatric Health Coach Academy argue that intensive, family‑based programs are proven effective yet...
Artificial intelligence is rapidly entering radiology, yet U.S. malpractice law still places physicians at the center of liability, even when AI tools err. Recent studies show jurors are more likely to hold radiologists responsible if they contradict an AI system,...
A new JAMA Health Forum analysis compares income‑related health system performance disparities in the United States and South Korea. Using MEPS, NHANES, KHPS and Korean NHANES data for over 400,000 adults, researchers examined spending, utilization, access, health status, risk factors...

The UK’s National Institute for Health and Care Excellence (NICE) has reopened its evaluation of Eli Lilly’s donanemab and Eisai’s lecanemab after initially rejecting them on cost grounds. A newly‑introduced cost‑effectiveness threshold of roughly £20,000 per quality‑adjusted life year (QALY)...

A new KFF poll finds that 41 % of U.S. adults think the Trump administration’s TrumpRx initiative will lower prescription drug costs, but confidence is split sharply along party lines. Overall worry about affording medications has risen to its highest level...
Saluja Medical Associates adopted Edge’s secure remote workforce platform, embedding eight to ten certified virtual assistants to handle insurance verification, scheduling, billing and call support. The model eliminated lengthy local hiring cycles, reduced turnover, and ensured compliance through supervised campus...

Patients with eczema continue to encounter significant insurance obstacles, according to a 2025 National Eczema Association (NEA) survey. The study found that 40% of respondents experienced coverage issues, 15% never began prescribed therapy, and step‑therapy and prior‑authorization requirements delayed treatment...

The US lets people sell their blood plasma, creating a multibillion-dollar industry (70% of global supply, 62.5M liters donated, $6.2B in exports) that saves countless lives and gives Americans a safe way to make a little cash (thus reducing their...
This week's Readout LOUD podcast is now available on all your favorite podcast outlets -- Stelios Papadopolous, the ‘godfather’ of biotech, in conversation with @damiangarde https://t.co/RHh5Qv9OyT via @statnews

Dr. James R. Kelly reports that enhancement rates for presbyopia‑correcting intraocular lenses have dropped from double‑digit levels in the early 2000s to roughly 5% by 2020, thanks to advances in lens optics and surgical technique. Residual refractive error under 0.5...
Cherish unveiled an AI‑enabled wearable that continuously records patient vitals such as heart rate and respiration. The device applies machine‑learning algorithms to establish individual baselines and flag subtle deviations that may signal health deterioration. Clinicians receive early alerts, enabling proactive...

The relationship between increased cardiorespiratory fitness (METS) and reduced risk of all-cause dementia, depression, and psychotic disorders. From over 4 million individuals in 27 studies @NatMentHealth [association, not cause and effect evidence] https://t.co/iQdGRc0Nrz

Robert F. Kennedy Jr., as HHS secretary, slashed $759 million in HIV research grants, eliminated half of the CDC’s HIV‑prevention divisions and redirected oversight to a new agency, jeopardizing a program that had driven new infections down more than 90 %. At...

Two randomized trials comparing conduction‑system pacing (CSP) with traditional biventricular (BiV) cardiac resynchronization therapy produced opposite results. The Chinese HeartSync‑LBBP study found that left‑bundle branch pacing reduced the composite of death or heart‑failure hospitalization and improved ventricular remodeling, while the...
Why should tumor whole genome sequencing (WGS) be done for cancer? In real practice of medicine study of 888 patients with solid cancers, WGS directly led to clinical consequences in over 40% @NatureMedicine https://t.co/kFho0yuLS7
Giant biotech round that hit right after I sent Pro Rata: Earendil Labs raises $787M https://t.co/NWt2bBA9Lr

A recent Evidation survey shows roughly one in seven U.S. adults on GLP‑1 drugs are microdosing, often to curb costs or chase longevity benefits without full‑dose side effects. Clinics like AgelessRx now market low‑dose regimens, while some physicians prescribe them...
caveat here is that it was routine when Prasad ran CBER (at least 4 overrules in Prasad's 10 mo. tenure) but it didn't/doesn't still seem to be happening elsewhere in FDA
Researchers have engineered a multifunctional hydrogel sensor by integrating a polyvinyl alcohol/silk fibroin double network with tannic‑acid‑coated liquid metal droplets, copper particles, and an ethanol post‑treatment. The resulting material exhibits a tensile strength of 1.452 MPa—483% higher than pure PVA—alongside 700%...

Healthcare AI is already reshaping clinical workflows, but governance lags behind. The FDA has cleared more than 1,400 AI‑enabled devices, yet post‑deployment monitoring remains weak, creating safety gaps. Industry leaders and the U.S. Senate are calling for national datasets and...
Political influence ‘a serious problem’ for FDA under Trump, former commissioner says https://t.co/52IR3LfECD via @statnews
The U.S. Food and Drug Administration has ordered a Class II recall of 89,592 bottles of 100‑mg/5‑ml Children’s Ibuprofen Oral Suspension after consumers reported gel‑like masses and black particles. The product, manufactured by India‑based Strides Pharma for Taro Pharmaceuticals USA, was...
The HIMSSCast episode spotlighted a new Nursing and Artificial Intelligence Innovation Consortium aimed at creating national standards for AI in patient care. Speakers emphasized that many AI tools succeed in labs but falter in real‑world nursing workflows, diverting clinicians from...
The future of promising therapeutics is on the line in the Trump administration's FDA, says the agency's former commissioner https://t.co/vyt49FkDsb
The National Assembly health committee warned that Kenya's Social Health Authority (SHA) is financially unsustainable, collecting roughly Sh7.4 billion monthly but spending Sh7.2 billion on operations. Only about 5 million of the 29 million registered members actually remit premiums, creating a large funding gap....

The UK Health Security Agency reported that the meningitis outbreak in Kent appears to have peaked, with only two new cases reported on Friday. To date, 18 confirmed and 11 probable cases have been recorded, totaling 29 infections, of which...

The first wave of healthcare AI delivered clear ROI by automating clinical documentation, turning high‑entropy encounter notes into structured, billable outputs. Vendors like Nuance DAX, Abridge, and Epic have made ambient scribes a table‑stake feature, driving productivity gains of several...
Good news for America’s children. ACIP was devoid of vaccine expertise and made harmful and ideologically driven recommendations that went against pediatric medical science. Hopefully we can rebuild pubic confidence in vaccines despite their efforts to undermine it, but it...

Mindray North America announced the launch of its SV900 and SV700 ventilators, marking the company’s entry into the U.S. respiratory‑care market. As the world’s second‑largest acute‑care ventilator supplier, Mindray is expanding its critical‑care portfolio with devices that combine invasive, non‑invasive...

The New York State Department of Health’s Bureau of Tobacco Control has issued an RFP for a public‑relations firm to design a statewide campaign exposing the tobacco industry’s role in the ongoing epidemic. The initiative will spotlight the industry’s impact...

The 7-1-7 framework sets three time‑bound targets—detect an outbreak within seven days, notify authorities within one day, and launch essential response actions within the next seven days. A Lancet Global Health analysis of 41 events in five African nations found...

The review of Aimee Donnellan’s book Off the Scales examines how Ozempic, a GLP‑1 drug originally for type‑2 diabetes, has become a blockbuster obesity treatment. It details the drug’s ability to deliver rapid 20%‑plus weight loss, its side‑effect profile, and...

Perfuze obtained FDA 510(k) clearance for its Millipede88 Aspiration Catheter after the MARRS clinical study met all primary objectives. The device is the first super‑bore 0.088 catheter cleared for standalone direct aspiration, featuring a patented corrugated design that preserves lumen...
The panel discussed practical approaches to EMR/EHR optimization, emphasizing that hidden workflow friction—not just software bugs—drives clinician burnout. They highlighted the need for combined quantitative analytics (e.g., usage dashboards, sentiment analysis) and qualitative methods (shadowing, listening sessions) to surface problems,...

Roche announced it will discontinue development of its anti‑myostatin antibody emugrobart for spinal muscular atrophy (SMA) after the Phase 2/3 MANATEE trial failed to demonstrate consistent muscle‑growth or motor‑function benefits. The study enrolled 259 patients and compared emugrobart plus Evrysdi against...
The FDA approved Rhythm Pharmaceuticals' once‑daily injection Imcivree for acquired hypothalamic obesity in adults and children aged four and up. Clinical trials showed an 18‑percentage‑point weight‑loss advantage over placebo, making it the first therapy for this rare, brain‑injury‑driven condition. Rhythm...
Respiratory support devices such as CPAP are increasingly used in home health settings, shifting maintenance responsibilities to patients. Poor hygiene—mask oil, tubing moisture, mineral deposits, and clogged filters—gradually degrades performance and can cause therapy abandonment. Automated UV‑C and ozone sanitizing...
The 2024‑2025 flu season has been unusually severe, with the CDC reporting 78 million cases, over a million hospitalizations and 67 000 deaths. Antiviral prescriptions are up 24% compared with the previous year, and Evernorth’s MD Live saw a 400% surge in flu‑related...
Physicians Di Micco and Siniscalchi commend the BLISS prognostic score, which estimates two‑year respiratory admissions for COPD patients in primary care. They argue that real‑world outcomes are heavily influenced by acute comorbidities such as pulmonary embolism, COVID‑19, and cancer, as well...

LinusBio has broadened its ClearStrand‑ASD hair‑based screening to children up to ten years old, extending beyond the original under‑48‑month validation. The test analyzes a single strand of hair with proprietary robotics and laser technology to detect metabolic patterns linked to...

Roche’s Genentech has halted the Phase III development of its muscle‑preserving therapy for spinal muscular atrophy (SMA) and facioscapulohumeral muscular dystrophy (FSHD). The decision follows disappointing efficacy signals and safety concerns that emerged in late‑stage trials. The program also included an...
NICE has agreed to revisit its June 2025 rejection of Eli Lilly’s Kisunla (donanemab) and Eisai’s Leqembi (lecanemab) for NHS reimbursement. The appeal will send the dossiers back to the appraisal committee to re‑examine clinical benefits, long‑term data, infusion costs and unpaid...

The UK Covid Inquiry’s Module 3 report, released on 19 March 2026, concluded that the "Stay Home, Protect the NHS" slogan likely discouraged people from seeking urgent medical care, contributing to avoidable non‑COVID deaths. The inquiry highlighted a sharp drop in A&E attendances,...

CNBC Cures, launched on Jan 8, 2026 by "Squawk Box" co‑host Becky Quick, is the network’s dedicated platform for rare‑disease awareness. Within two months it has produced a weekly newsletter, a podcast series, a live summit, and a prime‑time documentary titled “CNBC...
San Diego’s Rady Children’s Hospital halted gender‑affirming care for patients under 19, prompting four family lawsuits and a California Attorney General suit alleging breach of a 2034 merger agreement. The move adds to a wave of federal and state actions,...

Population health analytics using the Johns Hopkins ACG® System are now embedded across nearly 9 million NHS patients, roughly one in six people in England, via Graphnet Health platforms. This shift moves analytics from planning to routine operational use across Integrated...